Clinical Trial Liaison

About Us 

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.

It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.   Led by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.   We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.   At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.   These values are the foundation of our work, empowering us to make a real difference, every day.    

Job Title: CLINICAL TRIAL LIAISON (CTL)

Level: Director

Region: West - South San Francisco, Los Angeles, San Diego

Reports to: Senior Director or above, Clinical Operations

The Clinical Trial Liaison (CTL) will develop relationships with clinical trial investigators and research site staff to facilitate recruitment of subjects in Kardigan clinical trials.  The Clinical Trial Liaison (CTL) supports Global Development clinical study execution as the local field-based representative for Kardigan in one or more countries/regions supporting clinical development programs. The CTL interacts with investigator sites and other parties related to clinical trial execution.  Depending on trial needs and status, some periods will involve extensive travel, up to 70%, to support site teams, troubleshoot challenges, and foster strong, collaborative relationships.